このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

Healthcare Needs and Illness Experience in Children With Rare Genetic and Metabolic Diseases (TD/MPP_1)

2026年11月16日 更新者:Fondazione IRCCS San Gerardo dei Tintori

This prospective observational study aims to describe and characterize the multidimensional care needs of children and adolescents aged 1 month to 18 years with rare genetic and metabolic diseases, with particular emphasis on the identification of pediatric palliative care needs.

The study seeks to answer the question of which clinical, physical, psychological, social, and care-related needs characterize this population, and to what extent these needs are associated with complex care requirements and potential eligibility for pediatric palliative care.

Additional objectives include assessing pain, sleep disturbances, psychological well-being, quality of life, physical and social functioning, medication-related adverse events, symptom interference with daily life, and caregiver burden. The study will also explore individual care needs and the transition from pediatric to adult healthcare services.

A subgroup of approximately 150 participants will undergo longitudinal assessments every three months for up to 12 months to describe changes in care needs over time and identify factors potentially associated with worsening clinical and care complexity. Furthermore, a qualitative substudy involving caregivers and adolescents will explore the lived experience of illness and the meaning attributed to the disease by children and their families through semi-structured interviews.

Overall, the study aims to provide a comprehensive understanding of the care needs and illness experience of children with rare genetic and metabolic diseases, supporting the early identification of complex needs and the development of more personalized, proactive, and family-centered care pathways.

調査の概要

状態

まだ募集していません

研究の種類

観察的

入学 (推定)

800

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究連絡先

研究連絡先のバックアップ

研究場所

    • Italy
      • Monza、Italy、イタリア、20900
        • Fondazione IRCCS San Gerardo dei Tintori

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

1ヶ月~18年 (子、大人)

健康ボランティアの受け入れ

なし

受講資格のある性別

全て

サンプリング方法

非確率サンプル

調査対象母集団

Study participants will be consecutively recruited from the outpatient clinics of Metabolic Diseases and Clinical Genetics at Fondazione IRCCS San Gerardo dei Tintori, a tertiary referral hospital located in Monza, Italy. The study population will include patients attending these clinics for specialist assessment and follow-up. For the qualitative substudy, caregivers and eligible adolescent patients will be selected from the same clinical population.

説明

Inclusion Criteria:

  • Participants aged between 1 month and 18 years.
  • Diagnosis of a rare genetic or metabolic disease.
  • Written informed consent freely provided by the parents and/or legal guardians and obtained before study participation.

Exclusion Criteria:

  • Diagnosis of trisomy 21 (Down syndrome).
  • Unavailability of cultural mediators or language interpreters during the information and informed consent process, as well as during the assessment of patients or caregivers with limited or no understanding of the Italian language.

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 観測モデル:OTHER
  • 時間の展望:PROSPECTIVE

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
AccaPed Total Score for the Assessment of Complex Pediatric Palliative Care Needs
時間枠:At study enrollment for all participants; every three months for 12 months in a subgroup of approximately 150 participants.

The total score of the AccaPed scale will be used to assess complex pediatric palliative care needs. The assessment will be performed at study enrollment in all participants. In a subgroup of approximately 150 participants, the assessment will be repeated every three months for 12 months to describe changes in care needs over time.

At study enrollment for all participants; every three months for 12 months in a subgroup of approximately 150 participants.

二次結果の測定

結果測定
メジャーの説明
時間枠
Paediatric Palliative Care Needs
時間枠:At study enrollment for all participants; every three months for 12 months in a subgroup of approximately 150 participants.

The Paediatric Palliative Screening Scale (PaPaS) will be used to assess pediatric palliative care needs in participants aged 1 to 18 years. The assessment will be performed at study enrollment in all eligible participants. In a subgroup of approximately 150 participants, the assessment will be repeated every three months for 12 months to evaluate changes in palliative care needs over time.

At study enrollment for all participants; every three months for 12 months in a subgroup of approximately 150 participants.
Pain Intensity Assessment
時間枠:At study enrollment for all participants; every three months for 12 months in a subgroup of approximately 150 participants.

Pain intensity will be assessed using age- and cognitive status-appropriate validated tools: the Revised Face, Legs, Activity, Cry, Consolability scale (r-FLACC), the Face, Legs, Activity, Cry, Consolability scale (FLACC), the Wong-Baker FACES Pain Rating Scale, or the Numeric Rating Scale (NRS). The most appropriate instrument will be selected according to the participant's age and cognitive status. The assessment will be performed at study enrollment in all eligible participants and repeated in a subgroup of approximately 150 participants every three months for 12 months.

At study enrollment for all participants; every three months for 12 months in a subgroup of approximately 150 participants.
Assessment of Nociceptive Pain Phenotype
時間枠:At study enrollment for all eligible participants; every three months for 12 months in a subgroup of approximately 150 participants, where applicable.

The nociceptive pain phenotype will be characterized through the assessment of central and peripheral sensitization using simplified Quantitative Sensory Testing (QST), the identification of nociplastic pain according to the definition of the International Association for the Study of Pain (IASP), and the assessment of neuropathic pain using the PainDETECT Questionnaire (PD-Q). The assessment tools will be selected according to the participant's age and cognitive status. Assessments will be performed at study enrollment and repeated in a subgroup of approximately 150 participants every three months for 12 months, where applicable.

At study enrollment for all eligible participants; every three months for 12 months in a subgroup of approximately 150 participants, where applicable.
Sleep Disturbances Assessment
時間枠:At study enrollment for all eligible participants; every three months for 12 months in a subgroup of approximately 150 participants.

Sleep disturbances will be assessed using the Sleep Disturbance Scale for Children (SDSC) in participants aged 6 months to 18 years. The questionnaire will be completed by the researcher or caregiver. The assessment will be performed at study enrollment and repeated in a subgroup of approximately 150 participants every three months for 12 months.

At study enrollment for all eligible participants; every three months for 12 months in a subgroup of approximately 150 participants.
Psychological Well-being Assessment
時間枠:At study enrollment for all eligible participants; every three months for 12 months in a subgroup of approximately 150 participants.

Psychological aspects will be assessed using the Revised Children's Anxiety and Depression Scale (RCADS) in participants aged 8 to 18 years. The questionnaire will be completed by the researcher, caregiver, or participant, as appropriate. The assessment will be performed at study enrollment and repeated in a subgroup of approximately 150 participants every three months for 12 months.

At study enrollment for all eligible participants; every three months for 12 months in a subgroup of approximately 150 participants.
Pain Catastrophizing Assessment
時間枠:At study enrollment for all eligible participants; every three months for 12 months in a subgroup of approximately 150 participants.

Pain catastrophizing will be assessed using the Pain Catastrophizing Scale for Children (PCS-C) in participants aged 8 to 18 years. The questionnaire will be completed by the participant. The assessment will be performed at study enrollment and repeated in a subgroup of approximately 150 participants every three months for 12 months.

At study enrollment for all eligible participants; every three months for 12 months in a subgroup of approximately 150 participants.
Health-Related Quality of Life Assessment
時間枠:At study enrollment for all eligible participants; every three months for 12 months in a subgroup of approximately 150 participants.

Health-related quality of life will be assessed using the Pediatric Quality of Life Inventory (PedsQL) in participants aged 2 to 18 years. The appropriate version will be selected according to age, with the possibility of using the parent-proxy form for participants unable to complete the questionnaire because of age or cognitive impairment. The assessment will be performed at study enrollment and repeated in a subgroup of approximately 150 participants every three months for 12 months.

At study enrollment for all eligible participants; every three months for 12 months in a subgroup of approximately 150 participants.
Physical Function Assessment
時間枠:At study enrollment for all eligible participants; every three months for 12 months in a subgroup of approximately 150 participants.

Physical function will be assessed using the Gross Motor Function Classification System (GMFCS) in participants aged 1 to 18 years and the Function Disability Inventory (FDI) in participants aged 8 to 18 years. The FDI parent-report version may be used when required for children with cognitive difficulties. The assessment will be performed at study enrollment and repeated in a subgroup of approximately 150 participants every three months for 12 months.

At study enrollment for all eligible participants; every three months for 12 months in a subgroup of approximately 150 participants.
Social Function Assessment
時間枠:At study enrollment for all eligible participants; every three months for 12 months in a subgroup of approximately 150 participants.

Social function will be assessed using the KIDSCREEN-27 in participants aged 8 to 18 years, using the self-report or parent-proxy version as appropriate. The assessment will be performed at study enrollment and repeated in a subgroup of approximately 150 participants every three months for 12 months.

At study enrollment for all eligible participants; every three months for 12 months in a subgroup of approximately 150 participants.
Pharmacological Treatment, Perceived Benefit, and Adverse Events
時間枠:At study enrollment for all participants; every three months for 12 months in a subgroup of approximately 150 participants.

Pharmacological treatment will be characterized by recording the number and type of medications taken, the perceived benefit of treatment, and any reported medication-related adverse events. Treatment-related changes will also be assessed using the Patient Global Impression of Change (PGIC) in participants aged 8 to 18 years and the Observer Global Impression of Change (OGIC) parent-proxy form in participants with cognitive impairment. Assessments will be performed at study enrollment and repeated in a subgroup of approximately 150 participants every three months for 12 months.

At study enrollment for all participants; every three months for 12 months in a subgroup of approximately 150 participants.
Symptom Interference with Daily Life
時間枠:At study enrollment for all eligible participants; every three months for 12 months in a subgroup of approximately 150 participants.

The impact of symptoms on daily life will be assessed using the Symptom Screening in Pediatrics Tool (SSPedi). The self-report version will be used in participants aged 8 to 18 years, while the parent-proxy version will be used in participants aged 2 to 18 years, according to the participant's ability to complete the questionnaire. Assessments will be performed at study enrollment and repeated in a subgroup of approximately 150 participants every three months for 12 months.

At study enrollment for all eligible participants; every three months for 12 months in a subgroup of approximately 150 participants.
Caregiver Burden Assessment
時間枠:At study enrollment for all participants with an eligible caregiver assessment; every three months for 12 months in a subgroup of approximately 150 participants.

Caregiver burden will be assessed using the Caregiver Burden Inventory (CBI), completed by the caregiver. The assessment will be performed at study enrollment and repeated in a subgroup of approximately 150 participants every three months for 12 months.

At study enrollment for all participants with an eligible caregiver assessment; every three months for 12 months in a subgroup of approximately 150 participants.
Transition to Adult Healthcare Services
時間枠:During the 36-month study period.

The transition to adult healthcare services will be assessed by recording the proportion of patients requiring transfer to adult care, the proportion of patients for whom the transfer process has been initiated by 17 years and 6 months of age, and the proportion of patients effectively transferred to adult healthcare services upon reaching 18 years of age.

During the 36-month study period.
Individual Nursing Care Needs Classified According to ICNP
時間枠:At baseline; repeated every three months for 12 months in a subgroup of approximately 150 participants

Individual care needs will be identified and classified using the International Classification for Nursing Practice (ICNP), a standardized terminology for describing and documenting nursing practice. The assessment will support the systematic description of participants' individual nursing care needs.

At baseline; repeated every three months for 12 months in a subgroup of approximately 150 participants
Illness Experience and Meaning Attributed to the Disease by Children and Families
時間枠:Until data saturation is achieved during the study period.

The illness experience and the meaning attributed to the disease by children and their families will be explored through semi-structured interviews involving a subgroup of caregivers and adolescent participants aged 12 years or older. Interviews will be conducted until data saturation is achieved. The qualitative data will be analyzed to identify relevant themes concerning illness experience and care.

Until data saturation is achieved during the study period.

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (推定)

2026年11月1日

一次修了 (推定)

2029年11月1日

研究の完了 (推定)

2029年11月1日

試験登録日

最初に提出

2026年11月9日

QC基準を満たした最初の提出物

2026年11月16日

最初の投稿 (実際)

2026年11月18日

学習記録の更新

投稿された最後の更新 (実際)

2026年11月18日

QC基準を満たした最後の更新が送信されました

2026年11月16日

最終確認日

2026年11月1日

詳しくは

本研究に関する用語

その他の研究ID番号

  • TD/MPP_1
  • 7408 (その他の識別子:Comitato Etico Territoriale Lombardia 3 (Territorial Ethics Committee Lombardy 3))

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する